Samuel Chackalamannil

This inventor holds 77 USPTO granted patents and 7 published patent applications, plus 5 CIPO patents and 40 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Mochida Pharmaceutical Co., Ltd.. Active years: 1988-2018.

USPTO Granted Patents = 77 (Patent Applications = 7)

% Patents Active = 85.7

CIPO Patents = 5

EPO Patents = 40 (Patent Applications = 28)

Average Co-Inventor Count = 3.9

ph-index = 15

Forward Citations = 754(Granted Patents)

Forward Citations (Not Self Cited) = 673(Dec 10, 2025)

Inventors with similar research interests:

Location History:

W. Paterson, NJ (US) (1988 - 1992)
East Brunswick, NJ (US) (1995 - 2006)
Califon, NJ (US) (2005 - 2018)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

5 out of 229

Mochida Pharmaceutical Co., Ltd.

patents

4. 2 out of 52

Pharmacopeia Drug Discovery, Inc.

Intervet International B.v.

Schering-Plough Corporation

patents

10. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1988-2018

Loading Chart...

Areas of Expertise:

Factor IXa Inhibitors

Thrombin Receptor Antagonists

HCV NS3 Protease Inhibitors

BACE-1 Inhibitors

GPR119 Modulators

Pyrimidine Derivatives

Bicyclic Derivatives

Cyclic Amine Inhibitors

Cannabinoid Receptor Modulators

Adenosine Antagonists

Xanthine Phosphodiesterase V Inhibitors

Morpholinone Compounds

77 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9914727 - Factor IXa inhibitors (2018-03-13),

2. 9708308 - Factor IXa inhibitors (2017-07-18),

3. 9695198 - Factor IXa inhibitors (2017-07-04),

4. 9328138 - HCV NS3 protease inhibitors (2016-05-03),

5. 9161924 - Factor IXa inhibitors (2015-10-20),

6. 9062007 - Cyclic amide BACE-1 inhibitors having a benzamide substituent (2015-06-23),

7. 8987242 - Morpholinone compounds as factor IXA inhibitors (2015-03-24),

8. 8987195 - HCV NS3 protease inhibitors (2015-03-24),

9. 8980916 - Factor IXa inhibitors (2015-03-17),

10. 8912206 - Pyrimidine ether derivatives and methods of use thereof (2014-12-16),

11. 8907095 - Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119 (2014-12-09),

12. 8822480 - Bicyclic heterocycle derivatives and use thereof as GPR119 modulators (2014-09-02),

13. 8815876 - Bicyclic heterocycle derivatives and methods of use thereof (2014-08-26),

14. 8642582 - Morpholinone compounds as factor IXa inhibitors (2014-02-04),

15. 8623867 - Cyclic amine BACE-1 inhibitors having a benzamide substituent (2014-01-07),

Title: The Innovative Mind of Samuel Chackalamannil

Introduction: Samuel Chackalamannil, a talented inventor hailing from Califon, NJ (US), is known for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: Samuel Chackalamannil holds several patents in the field of renewable energy technologies, including a solar panel design that increases energy efficiency by 30% and a wind turbine blade material that enhances durability in harsh weather conditions.

Career Highlights: With a background in mechanical engineering, Samuel Chackalamannil has worked for leading tech companies where he spearheaded projects focused on sustainability and clean energy solutions. His dedication to creating environmentally friendly technologies has earned him recognition in the industry.

Collaborations: Throughout his career, Samuel Chackalamannil has collaborated with top researchers and engineers to bring his innovative ideas to life. His ability to work effectively in multidisciplinary teams has led to successful projects that have had a positive impact on the environment.

Conclusion: Samuel Chackalamannil's passion for innovation and commitment to developing sustainable technologies make him a standout figure in the world of inventors. His contributions continue to inspire future generations of inventors and engineers to push the boundaries of what is possible in the realm of renewable energy.